Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Clin Nucl Med. 2018 Sep;43(9):663–669. doi: 10.1097/RLU.0000000000002209

FIGURE 5.

FIGURE 5

(A) The relationship between the SUVmax of breast cancer and ER status. The SUVmax of ER-positive tumors was 4.97 ± 1.89 compared to 2.78 ± 0.65 in ER-negative tumors (P < 0.001). (B) The correlation between 68Ga-NOTA-RM26 PET SUVmax with GRPR expression level of breast cancer and lymph nodes expressed as immunoreactive score (r = 0.805, P < 0.001).